Breaking News, Collaborations & Alliances

Sterling Starts Large-scale Production of Nanologica’s Silica Particles

First commercial batch is expected to be delivered during 2021

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Global contract development and manufacturing organization (CDMO), Sterling Pharma Solutions has started large-scale production of Nanologica’s silica particles.   Nanologica is a nanotechnology company specializing in the development of silica for application in drug development and chromatography.   The company recently signed a long-term supply agreement with Chinese company, Yunbo Technology allowing Sterling to begin production.   Using Nanologica’s technology, Sterling will produce t...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters